Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of IL-4RαR576 Polymorphism on Response to Dupilumab in Asthma, a Genotype-stratified, Randomized, Placebo- Controlled Trial

NCT03694158 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03694158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03694158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of IL-4RαR576 Polymorphism on Response to Dupilumab in Asthma, a Genotype-stratified, Randomized, Placebo- Controlled Trial
Lead sponsor
Boston Children's Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 8, 2021
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

asthma